Skip to main content
Clinical Trials/ISRCTN95526224
ISRCTN95526224
Completed
未知

In vivo longitudinal evaluation of vertebral bone strength in patients with rheumatoid arthritis treated with alendronate

Kyushu University, Department of Orthopaedic Surgery (Japan)0 sites30 target enrollmentSeptember 10, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
Rheumatoid arthritis
Sponsor
Kyushu University, Department of Orthopaedic Surgery (Japan)
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2008 results in https://pubmed.ncbi.nlm.nih.gov/18975334/ (added 10/06/2021)

Registry
who.int
Start Date
September 10, 2007
End Date
August 21, 2003
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Kyushu University, Department of Orthopaedic Surgery (Japan)

Eligibility Criteria

Inclusion Criteria

  • Female postmenopausal patients with RA who met the American College of Rheumatology diagnostic criteria for RA.

Exclusion Criteria

  • 1\. The presence of abnormalities on spinal radiographs such as severe osteophytosis, scoliosis, spinal fusion, fracture deformation
  • 2\. Any disease known to affect bone turnover
  • 3\. Current or past glucocorticoid therapy comprising greater than 7\.5 mg/day (predonisone equivalent)
  • 4\. Current or past use of anabolic steroids, calcitonin, supplemental vitamin D or vitamin K, bisphosphonate
  • 5\. Current or past hormone replacement therapy
  • 6\. Spinal areal Bone Mineral Density (BMD) T\-score greater than \-1\.0

Outcomes

Primary Outcomes

Not specified

Similar Trials